Login to Your Account

Here we go again

Industry basks in JPM spotlight and stock values benefit, too

By Peter Winter

Tuesday, January 21, 2014

SAN FRANCISCO – What a fantastic week for the biotech industry. As the doors closed on the 32nd Annual J. P. Morgan Healthcare Conference last week, delegates will surely have left with the lasting impression, if they hadn’t formed it before, that the sector is alive and well and poised for another great year.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription